Robert Noecker, MD
UPMC Eye Center
5
5
5
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (5)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Ahmed A Tabl, MD
Benha University
Shared therapeutic areas:
Ali MA Ismail, lecturer
Cairo University
Shared therapeutic areas:
David Huang, MD, PhD
Oregon Health and Science University
Shared therapeutic areas:
Jeff Wells, PharmD, MBA
Glaukos Corporation
Shared therapeutic areas:
Weerawat Kiddee, MD
Prince of Songkla University
Shared therapeutic areas:
Anastasios G Konstas, MD, PhD
Glaucoma Unit, 1st University Department of Ophthalmology
Shared therapeutic areas:
Georgios Labiris, MD,PhD
Department of Ophthalmology, University Hospital of Alexandroupolis, Alexandroupolis, Greece
Shared therapeutic areas:
Selim Orgül, MD
University Hospital, Basel, Switzerland
Shared therapeutic areas:
ali ismail, lecturer
Cairo University
Shared therapeutic areas:
Jeffrey L Goldberg, MD PhD
Stanford University
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (5)
Showing 5 of 5 trials
Diurnal Curves With Bimatoprost 0.03% Versus Travoprost 0.004%
Efficacy of Bimatoprost 0.03% in Patients Who Are Low-Responders to Latanoprost
Bimatoprost Monotherapy vs. Dual Therapy With Travoprost and Timolol in Patients With Glaucoma and Ocular Hypertension
A Multicenter Evaluation of Methods to Reduce Hyperemia Associated With Bimatoprost Therapy for Glaucoma or Ocular Hypertension
Brimonidine Purite 0.15% Versus Dorzolamide 2% Used as Adjunctive Therapy to Latanoprost
All 5 trials loaded